13D Filing: Great Point Partners and Connecture Inc (CNXR)
Please follow Great Point Partners (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Great Point Partners or update its stock...
Posts Tagged ‘Great Point Partners’
13G Filing: Great Point Partners and Catalyst Pharmaceuticals Inc. (CPRX)
Please follow Great Point Partners (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Great Point Partners or update its stock...
13G Filing: Great Point Partners and Adamas Pharmaceuticals Inc (ADMS)
Please follow Great Point Partners (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Great Point Partners or update its stock...
13G Filing: Great Point Partners and Kura Oncology Inc (KURA)
You can access the original SEC filing by clicking here.
13G Filing: Great Point Partners and PTC Therapeutics Inc. (PTCT)
You can access the original SEC filing by clicking here.
13G Filing: Great Point Partners and Newlink Genetics Corp (NLNK)
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent...
13G Filing: Great Point Partners and Foamix Pharmaceuticals Ltd (FOMX)
You can access the original SEC filing by clicking here.
Inotek Pharmaceuticals Corp (ITEK): Great Point Partners Adds to Its Position
Jeffrey Jay and David Kroin's Great Point Partners has raised its stake in Inotek Pharmaceuticals Corp (NASDAQ:ITEK) to 1.37 million shares, which represent 5.07% of the float...
This Biotech Hedge Fund’s Stock Picks Killed It in Q3
Hedge funds returned about 4% so far this year and underperformed the S&P 500 Index again.
Daily Wrap: The Biggest Hedge Fund Moves of the Day
Billionaire Daniel S. Och‘s OZ Capital Management initiated a position in Nutanix Inc. (NASDAQ:NTNX), as reported in a 13G filing yesterday.
Foamix Pharmaceuticals Ltd. (FOMX) Stock: Great Point Partners Boosts its Stake to 7.57%
Jeffrey Jay and David Kroin's Great Point Partners recently filed a Form 13G with the Securities and Exchange Commission in which it reported a significant increase to its stake...
Alimera Sciences Inc (ALIM): Great Point Partners Reveals 5.12% Stake
Jeffrey Jay and David Kroin's Great Point Partners reported the acquisition of 3.25 million common shares of Alimera Sciences Inc (NASDAQ:ALIM) which account for 5.12% of the...
Ignyta Inc. (RXDX): Great Point Partners Reports New Stake
In a recent 13G filing with the US SEC, Jeffrey Jay and David Kroin's Great Point Partners reported the acquisition of 2.05 million shares of Ignyta Inc.
13D Filing: Great Point Partners and Bovie Medical Corp (BVX)
You can access the original SEC filing by clicking here.
Jeffrey Ray’s Great Point Partners Trims Its Stake In Alcobra Ltd (ADHD)
Jeffrey Jay and David Kroin's healthcare-focused fund, Great Point Partners, decreased its passive stake in the Israel based biopharmaceutical company, Alcobra Ltd (NASDAQ...
Connecture Inc (CNXR), Hyperion Therapeutics Inc (HPTX): Top 5 Healthcare Picks of Great Point Partners
Jeffrey Jay and David Kroin’s Great Point Partners is one of the newer funds we track at Insider Monkey, and we’ll cover the healthcare-focused fund’s top picks for the ...
PowerSecure International Inc. (POWR), Anthera Pharmaceuticals Inc (ANTH): Broadfin Capital and Becker Drapkin Management’s Recent Bullish Moves
Last Friday, Kevin Kotler’s Broadfin Capital disclosed a marked increase (of almost 70%) in its exposure to Anthera Pharmaceuticals Inc (NASDAQ:ANTH).
VIRGINIA NATL BNK (VABK), Alimera Sciences Inc (ALIM), Advanced Photonix, Inc. (API): Hedge Funds Disclose Moves In Their Equity Portfolios
Tim Mullen and his fund, Swift Run Capital Management, have sent a presentation to the management of VIRGINIA NATL BNK (OTCMKTS:VABK), in which they have outlined potential ...
